Document is current
Any future updates will be listed below
-
Authors
Dahlberg, Audun Olav
Aase, Audun
Reiso, Harald
Thortveit, Erik
Eikeland, Randi
Engstrøm, Morten
Midgard, Rune
-
Funding
Funding for this research was provided by:
NTNU Norwegian University of Science and Technology
- License Information
-
More Information
Article History
Received: 8 November 2024
Accepted: 12 May 2025
First Online: 16 May 2025
Change Date: 7 July 2025
Change Type: Update
Change Details: This article has been updated to amend the license information.
Declarations
:
: The study was approved by the Regional Committee for Medical and Health Research Ethics in South-East Norway (Reference number REK 2018/759 and REK 2013/2082). Informed consent was obtained from all participants, and the participants could withdraw their consent at any time. The study was carried out according to the Declaration of Helsinki.
: Not applicable.
: RE received reimbursement of travel costs and lecture honorarium from Pfizer. The other authors declare that they have no competing interests.
: Not applicable.
